{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T13:18:22Z","timestamp":1768828702619,"version":"3.49.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T00:00:00Z","timestamp":1656892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>The burden of ischaemia is a risk factor for adverse outcomes in ischaemic cardiomyopathy (ICM) but is not systematically tested when deciding on revascularization. Limited data exists in patients with ICM regarding the interaction between ischaemia and early coronary revascularization (ECR). This study sought to determine if the burden of ischaemia modifies the outcomes of ECR in ICM.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>Consecutive patients with ICM (left ventricular ejection fraction\u2009&amp;lt;\u200940%) with a stress-rest gated single-photon emission computed tomography (N\u2009=\u2009747) were followed-up for ECR and major cardiovascular events (MACEs, cardiovascular death, myocardial infarction, or heart failure hospitalization). A 1:1 matched population was selected using a propensity score for ECR. The interaction between ischaemia and ECR was evaluated in the matched cohort. In the initial cohort, 131 patients underwent ECR. Of them, 109 were matched to non-ECR patients. After a median follow up of 4.1 years, 102 (46.8%) patients experienced a MACE. The effect of revascularization on MACE was dependent of the percent of ischaemia (P for the interaction at 10% ischaemia\u2009=\u20090.021), so that a trend towards a decreased risk of MACE was seen in patients with &amp;gt;10% of ischaemia [hazard ratio (HR)\u2009=\u20090.59 (0.30\u20131.18)], whereas a non-significant increase of MACE was observed in those with &amp;lt;10% ischaemia (HR\u2009=\u20091.67 [0.94\u20132.96]).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In a contemporary cohort of patients with ICM, the beneficial effects of ECR may be mediated by the percent of ischaemia. This study supports stress testing in ICM and an ischaemia-guided approach for ECR.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjci\/jeac125","type":"journal-article","created":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T08:36:27Z","timestamp":1656923787000},"page":"1304-1311","source":"Crossref","is-referenced-by-count":3,"title":["Impact of revascularization guided by functional testing in ischaemic cardiomyopathy"],"prefix":"10.1093","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1638-7820","authenticated-orcid":false,"given":"Eduard","family":"R\u00f3denas-Alesina","sequence":"first","affiliation":[{"name":"Cardiology Department, Vall d\u2019Hebron University Hospital, Vall d\u2019Hebron Research Institute, Universitat Aut\u00f2noma de Barcelona , Barcelona , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4404-6337","authenticated-orcid":false,"given":"Guillermo","family":"Romero-Farina","sequence":"additional","affiliation":[{"name":"Nuclear Cardiology Department, Vall d\u2019Hebron University Hospital, Vall d\u2019Hebron Research Institute. Universitat Aut\u00f2noma de Barcelona , Pg. Vall d\u2019Hebron, 119-129, 08035 Barcelona , Spain"},{"name":"Centro de investigaci\u00f3n biom\u00e9dica en red: enfermedades cardiovasculares (CIBER-CV) , 28029 Madrid , Spain"},{"name":"Medicine and Cardiology Department, Consorci Sanitari de l\u2019Alt Pened\u00e8s I Garraf (CSAPG) , 08720 Vilafranca del Pened\u00e8s, Barcelona , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Jord\u00e1n","sequence":"additional","affiliation":[{"name":"Cardiology Department, Vall d\u2019Hebron University Hospital, Vall d\u2019Hebron Research Institute, Universitat Aut\u00f2noma de Barcelona , Barcelona , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"Herrador","sequence":"additional","affiliation":[{"name":"Cardiology Department, Vall d\u2019Hebron University Hospital, Vall d\u2019Hebron Research Institute, Universitat Aut\u00f2noma de Barcelona , Barcelona , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carina","family":"Espinet-Coll","sequence":"additional","affiliation":[{"name":"Nuclear Cardiology Department, Vall d\u2019Hebron University Hospital, Vall d\u2019Hebron Research Institute. Universitat Aut\u00f2noma de Barcelona , Pg. Vall d\u2019Hebron, 119-129, 08035 Barcelona , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Nazarena","family":"Pizzi","sequence":"additional","affiliation":[{"name":"Cardiology Department, Vall d\u2019Hebron University Hospital, Vall d\u2019Hebron Research Institute, Universitat Aut\u00f2noma de Barcelona , Barcelona , Spain"},{"name":"Centro de investigaci\u00f3n biom\u00e9dica en red: enfermedades cardiovasculares (CIBER-CV) , 28029 Madrid , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aida","family":"Ribera","sequence":"additional","affiliation":[{"name":"Cardiology Department, Vall d\u2019Hebron University Hospital, Vall d\u2019Hebron Research Institute, Universitat Aut\u00f2noma de Barcelona , Barcelona , Spain"},{"name":"Centro de investigaci\u00f3n biom\u00e9dica en red: epidemiolog\u00eda y salud p\u00fablica (CIBER-ESP) , 28029 Madrid , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 A","family":"Barrab\u00e9s","sequence":"additional","affiliation":[{"name":"Cardiology Department, Vall d\u2019Hebron University Hospital, Vall d\u2019Hebron Research Institute, Universitat Aut\u00f2noma de Barcelona , Barcelona , Spain"},{"name":"Centro de investigaci\u00f3n biom\u00e9dica en red: enfermedades cardiovasculares (CIBER-CV) , 28029 Madrid , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Aguad\u00e9-Bruix","sequence":"additional","affiliation":[{"name":"Nuclear Cardiology Department, Vall d\u2019Hebron University Hospital, Vall d\u2019Hebron Research Institute. Universitat Aut\u00f2noma de Barcelona , Pg. Vall d\u2019Hebron, 119-129, 08035 Barcelona , Spain"},{"name":"Centro de investigaci\u00f3n biom\u00e9dica en red: enfermedades cardiovasculares (CIBER-CV) , 28029 Madrid , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Ferreira-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Cardiology Department, Vall d\u2019Hebron University Hospital, Vall d\u2019Hebron Research Institute, Universitat Aut\u00f2noma de Barcelona , Barcelona , Spain"},{"name":"Centro de investigaci\u00f3n biom\u00e9dica en red: epidemiolog\u00eda y salud p\u00fablica (CIBER-ESP) , 28029 Madrid , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,7,4]]},"reference":[{"issue":"16","key":"2022091014190893300_jeac125-B1","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJMoa1602001","article-title":"Coronary-artery bypass surgery in patients with ischemic cardiomyopathy","volume":"374","author":"Velazquez","year":"2016","journal-title":"N Engl J Med [Internet]"},{"issue":"10244","key":"2022091014190893300_jeac125-B2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(20)30748-0","article-title":"Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials","volume":"396","author":"Vaduganathan","year":"2020","journal-title":"Lancet (London, England)"},{"issue":"17","key":"2022091014190893300_jeac125-B3","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJMoa1100358","article-title":"Myocardial viability and survival in ischemic left ventricular dysfunction","volume":"364","author":"Bonow","year":"2011","journal-title":"N Engl J Med [Internet]"},{"issue":"23","key":"2022091014190893300_jeac125-B4","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1161\/01.CIR.0000072790.23090.41","article-title":"Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography","volume":"107","author":"Hachamovitch","year":"2003","journal-title":"Circulation"},{"issue":"15","key":"2022091014190893300_jeac125-B5","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N Engl J Med [Internet]"},{"issue":"15","key":"2022091014190893300_jeac125-B6","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N Engl J Med"},{"issue":"3","key":"2022091014190893300_jeac125-B7","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1056\/NEJMoa1803538","article-title":"Five-year outcomes with PCI guided by fractional flow reserve","volume":"379","author":"Xaplanteris","year":"2018","journal-title":"N Engl J Med [Internet]"},{"issue":"2","key":"2022091014190893300_jeac125-B8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jjcc.2014.11.007","article-title":"Time to and risk of cardiac events after myocardial perfusion scintigraphy","volume":"66","author":"Nudi","year":"2015","journal-title":"J Cardiol [Internet]"},{"issue":"13","key":"2022091014190893300_jeac125-B9","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.jacc.2019.07.055","article-title":"Extent of myocardial ischemia on positron emission tomography and survival benefit with early revascularization","volume":"74","author":"Patel","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"2022091014190893300_jeac125-B10","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.120.050304","article-title":"Initial invasive versus conservative management of stable ischemic heart disease in patients with a history of heart failure or left ventricular dysfunction: insights from the ISCHEMIA trial","volume":"142","author":"Lopes","year":"2020","journal-title":"Circulation"},{"issue":"2","key":"2022091014190893300_jeac125-B11","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0735-1097(01)01738-7","article-title":"A standardized definition of ischemic cardiomyopathy for use in clinical research","volume":"39","author":"Felker","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2022091014190893300_jeac125-B12","first-page":"225","article-title":"Analysis of apical remodeling in gated myocardial perfusion SPECT imaging in ischemic cardiomyopathy","volume":"15","author":"Romero-Farina","year":"2008","journal-title":"J Nucl Cardiol Off Publ Am Soc Nucl Cardiol"},{"key":"2022091014190893300_jeac125-B13","first-page":"ehy394","article-title":"2018 ESC\/EACTS guidelines on myocardial revascularization","author":"Neumann","year":"2018","journal-title":"Eur Heart J [Internet]"},{"key":"2022091014190893300_jeac125-B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/eurheartj\/ehy394\/5079120","article-title":"2018 ESC\/EACTS guidelines on myocardial revascularization","author":"Neumann","year":"2018","journal-title":"Eur Heart J [Internet]"},{"key":"2022091014190893300_jeac125-B15","first-page":"1674","article-title":"Vasodilator stress CMR and all-cause mortality in stable ischemic heart disease: a large retrospective registry","volume":"13","author":"Marcos-Garces","year":"2020","journal-title":"JACC: Cardiovascular Imaging"},{"issue":"10","key":"2022091014190893300_jeac125-B16","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/RLU.0b013e318263907b","article-title":"Relationship between myocardial perfusion-gated SPECT and the performance of coronary revascularization in patients with ischemic cardiomyopathy","volume":"37","author":"Romero-Farina","year":"2012","journal-title":"Clin Nucl Med"},{"issue":"3","key":"2022091014190893300_jeac125-B17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.remn.2010.12.006","article-title":"[Impact of myocardial perfusion gated-SPECT on the decision to perform coronary angiography in patients with left ventricular dysfunction of ischemic origin]","volume":"30","author":"Romero-Farina","year":"2011","journal-title":"Rev Esp Med Nucl"},{"issue":"17","key":"2022091014190893300_jeac125-B18","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJMoa1100356","article-title":"Coronary-artery bypass surgery in patients with left ventricular dysfunction","volume":"364","author":"Velazquez","year":"2011","journal-title":"N Engl J Med"},{"issue":"5","key":"2022091014190893300_jeac125-B19","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1157\/13119999","article-title":"[Effect of coronary revascularization in patients with ischemic cardiomyopathy who satisfy viability criteria on gated-SPECT assessment of myocardial perfusion]","volume":"61","author":"Romero-Farina","year":"2008","journal-title":"Rev Esp Cardiol"},{"issue":"1","key":"2022091014190893300_jeac125-B20","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1186\/s12872-020-01726-4","article-title":"The effect of revascularization on mortality and risk of ventricular arrhythmia in patients with ischemic cardiomyopathy","volume":"20","author":"Alkharaza","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"2022091014190893300_jeac125-B21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1067\/mhj.2002.119996","article-title":"Revascularization improves survival in ischemic cardiomyopathy regardless of electrocardiographic criteria for prior small-to-medium myocardial infarcts","volume":"143","author":"Shah","year":"2002","journal-title":"Am Heart J"},{"issue":"8","key":"2022091014190893300_jeac125-B22","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehq500","article-title":"Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy","volume":"32","author":"Hachamovitch","year":"2011","journal-title":"Eur Heart J"},{"issue":"6","key":"2022091014190893300_jeac125-B23","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.nuclcard.2006.08.017","article-title":"Predicting therapeutic benefit from myocardial revascularization procedures: Are measurements of both resting left ventricular ejection fraction and stress-induced myocardial ischemia necessary?","volume":"13","author":"Hachamovitch","year":"2006","journal-title":"J Nucl Cardiol"},{"issue":"18","key":"2022091014190893300_jeac125-B24","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.jacc.2013.02.014","article-title":"Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction","volume":"61","author":"Panza","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2022091014190893300_jeac125-B25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/CIRCIMAGING.112.000138","article-title":"Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium","volume":"6","author":"Ling","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"issue":"6","key":"2022091014190893300_jeac125-B26","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jacc.2014.04.064","article-title":"Extent of coronary and myocardial disease and benefit from surgical revascularization in ischemic LV dysfunction [corrected]","volume":"64","author":"Panza","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"11 Suppl 1","key":"2022091014190893300_jeac125-B27","first-page":"S3","article-title":"Survival in patients with severe ischemic cardiomyopathy undergoing revascularization versus medical therapy: association with end-systolic volume and viability","volume":"126","author":"Kwon","year":"2012","journal-title":"Circulation"}],"container-title":["European Heart Journal - Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/23\/10\/1304\/45786556\/jeac125.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/23\/10\/1304\/45786556\/jeac125.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T14:20:23Z","timestamp":1662819623000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article\/23\/10\/1304\/6628344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,4]]},"references-count":27,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,7,4]]},"published-print":{"date-parts":[[2022,9,10]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjci\/jeac125","relation":{},"ISSN":["2047-2404","2047-2412"],"issn-type":[{"value":"2047-2404","type":"print"},{"value":"2047-2412","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,10,1]]},"published":{"date-parts":[[2022,7,4]]}}}